Resectable pancreatic cancer: the role for neoadjuvant/preoperative therapy.
作者信息
Evans Douglas B
机构信息
Department of Surgical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
出版信息
HPB (Oxford). 2006;8(5):365-8. doi: 10.1080/13651820600804005.
Abstract
摘要
相似文献
1
Resectable pancreatic cancer: the role for neoadjuvant/preoperative therapy.可切除胰腺癌：新辅助/术前治疗的作用
HPB (Oxford). 2006;8(5):365-8. doi: 10.1080/13651820600804005.
2
Contemporary trials evaluating neoadjuvant therapy for resectable pancreatic cancer.当代评估可切除胰腺癌新辅助治疗的临床试验。
J Surg Oncol. 2021 May;123(6):1423-1431. doi: 10.1002/jso.26393.
3
[Developments and controversies in neoadjuvant therapy for resectable pancreatic cancer].[可切除胰腺癌新辅助治疗的进展与争议]
Zhonghua Wai Ke Za Zhi. 2020 Jul 1;58(7):486-489. doi: 10.3760/cma.j.cn112139-20200422-00318.
4
Low lymphocyte monocyte ratio after neoadjuvant therapy predicts poor survival after pancreatectomy in patients with borderline resectable pancreatic cancer.新辅助治疗后淋巴细胞单核细胞比值低提示边界可切除胰腺癌患者胰切除术后生存不良。
Surgery. 2019 Jun;165(6):1151-1160. doi: 10.1016/j.surg.2018.12.015. Epub 2019 Feb 11.
5
Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery.可切除交界性胰腺癌患者接受新辅助治疗和手术的生存情况。
Surgery. 2019 Sep;166(3):277-285. doi: 10.1016/j.surg.2019.05.010. Epub 2019 Jul 2.
6
Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades.过去二十年中可切除胰腺癌新辅助治疗的进展。
Ann Hepatobiliary Pancreat Surg. 2021 May 31;25(2):179-191. doi: 10.14701/ahbps.2021.25.2.179.
7
Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy.可切除边缘性胰腺癌及新辅助放化疗的作用
Updates Surg. 2016 Sep;68(3):235-239. doi: 10.1007/s13304-016-0392-x. Epub 2016 Sep 15.
8
Neoadjuvant Therapy is Associated with Improved Survival in Borderline-Resectable Pancreatic Cancer.新辅助治疗与边界可切除胰腺癌患者生存改善相关。
Ann Surg Oncol. 2020 Apr;27(4):1191-1200. doi: 10.1245/s10434-019-08087-z. Epub 2019 Dec 4.
9
Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer.可切除和交界可切除胰腺癌新辅助治疗和手术后首次疾病复发的放射学模式。
Surgery. 2020 Sep;168(3):440-447. doi: 10.1016/j.surg.2020.04.031. Epub 2020 Jul 5.
10
Neoadjuvant and Adjuvant Therapy in Operable Pancreatic Cancer: Both Honey and Milk (but No Bread?).可切除胰腺癌的新辅助治疗和辅助治疗：蜜与乳兼得（但无面包？）
Oncol Ther. 2021 Jun;9(1):1-12. doi: 10.1007/s40487-020-00136-y. Epub 2021 Jan 13.
引用本文的文献
1
Defining the Optimal Duration of Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Time for a Personalized Approach?定义新辅助治疗胰腺导管腺癌的最佳时间：是否需要个性化治疗？
Pancreas. 2022 Oct 1;51(9):1083-1091. doi: 10.1097/MPA.0000000000002147.
2
CA19-9 Change During Neoadjuvant Therapy May Guide the Need for Additional Adjuvant Therapy Following Resected Pancreatic Cancer.CA19-9 水平在新辅助治疗期间的变化可能指导接受手术治疗后的胰腺癌患者是否需要辅助治疗。
Ann Surg Oncol. 2020 Oct;27(10):3950-3960. doi: 10.1245/s10434-020-08468-9. Epub 2020 Apr 22.
3
Development of a Novel Multiparametric MRI Radiomic Nomogram for Preoperative Evaluation of Early Recurrence in Resectable Pancreatic Cancer.开发一种新型多参数 MRI 放射组学列线图，用于术前评估可切除胰腺癌的早期复发。
J Magn Reson Imaging. 2020 Jul;52(1):231-245. doi: 10.1002/jmri.27024. Epub 2019 Dec 23.
4
Systemic neoadjuvant chemotherapy in modern pancreatic cancer treatment: a systematic review and meta-analysis.现代胰腺癌治疗中的全身新辅助化疗：一项系统评价与荟萃分析
Ann R Coll Surg Engl. 2019 Sep;101(7):453-462. doi: 10.1308/rcsann.2019.0060. Epub 2019 Jul 15.
5
Is Neoadjuvant Therapy Sufficient in Resected Pancreatic Cancer Patients? A National Study.新辅助治疗在可切除胰腺癌患者中是否足够？一项全国性研究。
J Gastrointest Surg. 2018 Feb;22(2):214-225. doi: 10.1007/s11605-017-3541-8. Epub 2017 Oct 4.
6
Complete Response after Treatment with Neoadjuvant Chemoradiation with Prolonged Chemotherapy for Locally Advanced, Unresectable Adenocarcinoma of the Pancreas.新辅助放化疗联合延长化疗治疗局部晚期、不可切除胰腺癌后的完全缓解
Case Rep Oncol Med. 2017;2017:7834702. doi: 10.1155/2017/7834702. Epub 2017 Mar 8.
7
Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer.新辅助治疗在老年胰腺癌多模式治疗中的作用。
J Am Coll Surg. 2014 Jul;219(1):111-20. doi: 10.1016/j.jamcollsurg.2014.02.023. Epub 2014 Mar 13.
8
Clinical predictors of resectability of pancreatic adenocarcinoma.胰腺癌可切除性的临床预测因素。
Saudi J Gastroenterol. 2013 Nov-Dec;19(6):278-85. doi: 10.4103/1319-3767.121036.
9
Imaging in staging and management of pancreatic ductal adenocarcinoma.胰腺导管腺癌分期及管理中的影像学检查
Indian J Surg Oncol. 2011 Jun;2(2):78-87. doi: 10.1007/s13193-010-0017-7. Epub 2010 Dec 23.
10
Self-expanding metal stents for biliary drainage in patients with resectable pancreatic cancer: single-center experience with 79 cases.可切除胰腺癌患者胆道引流用自膨式金属支架：单中心 79 例经验。
Dig Dis Sci. 2011 Dec;56(12):3678-84. doi: 10.1007/s10620-011-1815-7. Epub 2011 Jul 13.
本文引用的文献
1
Borderline resectable pancreatic cancer.可切除边缘的胰腺癌。
Curr Treat Options Gastroenterol. 2005 Oct;8(5):377-84. doi: 10.1007/s11938-005-0040-x.
2
Combined-modality treatment for operable pancreatic adenocarcinoma.可切除胰腺腺癌的综合治疗
Oncology (Williston Park). 2005 Mar;19(3):393-404, 409; discussion 409-10, 412-6.
3
Neoadjuvant therapy for resectable pancreatic cancer.可切除胰腺癌的新辅助治疗
Surg Oncol Clin N Am. 2004 Oct;13(4):639-61, ix. doi: 10.1016/j.soc.2004.06.007.
4
Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome.术前使用紫杉醇并同步快速分割放疗治疗可切除胰腺腺癌：毒性、组织学反应率及无事件生存期
J Clin Oncol. 2002 May 15;20(10):2537-44. doi: 10.1200/JCO.2002.11.064.
5
Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma.吉西他滨联合放疗治疗局部晚期胰腺腺癌的Ⅰ期试验
Clin Cancer Res. 2001 Aug;7(8):2246-53.
6
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration.胰腺癌的新辅助放化疗：治疗变量与生存时长
Ann Surg Oncol. 2001 Mar;8(2):123-32. doi: 10.1007/s10434-001-0123-4.
7
Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma.可切除胰腺癌的快速分割术前放化疗、胰十二指肠切除术及术中放射治疗
J Clin Oncol. 1998 Dec;16(12):3843-50. doi: 10.1200/JCO.1998.16.12.3843.
8
Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas.胰腺癌的术前放化疗及胰十二指肠切除术
Arch Surg. 1992 Nov;127(11):1335-9. doi: 10.1001/archsurg.1992.01420110083017.
Zotero 插件